Sunesis to Present at the 2014 Wells Fargo Healthcare Conference
June 11 2014 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Eric Bjerkholt, Executive Vice President, Corporate Development and
Finance at Sunesis, will be presenting at the 2014 Wells Fargo
Healthcare Conference on Tuesday, June 17, 2014 at 1:10 PM Eastern
Time at the InterContinental Hotel in Boston.
A live webcast of the presentation will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcast
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, Qinprezo, in multiple
indications to improve the lives of people with cancer.
For additional information on Sunesis, please visit
http://www.sunesis.com.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024